The agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it ...
The cost of drugs in the U.S. continues to skyrocket. The average drug price increase from 2022 to 2023 was 15%, according to ...
The FTC recently announced that it has sent another round of letters disputing additional patent listings in the FDA’s Orange Book. With this latest action, the FTC has now challenged hundreds of ...
"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given ...
Several drug stocks are at risk as the Federal Trade Commission is going after pharmaceutical companies that it alleges are ...
FTC released its Fiscal Year 2023 Annual Report outlining the agency’s work to protect consumers and promote competition.